Brief: Glenmark Pharma Receives U.S. FDA Approval For Progesterone Vaginal Inserts, 100 Mg
09/04/2026 06:42
April 9 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: RECEIVES U.S. FDA APPROVAL FOR PROGESTERONE VAGINAL INSERTS, 100 MG Source text: ID:nNSE8j4qcP Further company coverage: GLEN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter